Shanghai Pharma's Capital Chess Game: Retreat or Strategic Pivot?

It's like a startup that just closed its seed round, then immediately sells some equity to strategic investors while also participating in a new fund—seemingly contradictory, but actually hiding deeper intentions. Shanghai Pharmaceuticals' combo move of "selling subsidiary equity + investing in an industrial fund" isn't new in the capital circles, but announcing it on the same day is worth every entrepreneur thinking carefully about.